All Articles

Tesla's massive Q2 delivery beat quiets demand fears, but a huge inventory drawdown and looming capital costs raise critical questions for its July earnings call.

As heatwaves become the new normal, simple fans are failing. Aecooly’s new misting tech signals a shift from moving air to creating personal microclimates.

With consumer delinquencies rising, KredosAi's AI platform just raised $7M, led by BMW i Ventures, to make debt collection more human and effective.

After a successful FIFA World Cup debut, ADI Predictstreet is expanding. We explore how Gibraltar's regulatory gambit and blockchain tech are creating a new global forecasting tool.

A new tech partnership promises to fix senior living's data chaos. But the real story is how connected systems can restore dignity and humanity to elder care.

As AI search overwhelms marketers with data, Profound's new 'Aim' agent promises to cut through the noise, turning endless metrics into actionable strategy.

With a 10% dividend boost, Kish showcases how a diversified model, tech investment, and community focus create sustained value for long-term investors.

A landmark deal brings biochar to America's roads. It's a pragmatic shift toward sustainable infrastructure with a lucrative carbon credit-backed model.

An inside look at how Chengdu is pairing high-tech industrial might with aggressive global outreach to redefine itself as a critical node in tech and biotech.

Amidst FDA warning letters and costly recalls, Integra LifeSciences appoints Topaz Kirlew as its new regulatory chief. It's a critical test of leadership.

As Atlanta's Ameris Bancorp preps its Q2 report, its results will offer a key signal on the Southeast's economic health amid rate cuts and market shifts.

Mawer's new fund brings private equity to the masses, but this move from public market safety to private complexity carries risks alongside its rewards.

The recent funding for Luxonis isn't just another AI investment. It’s a validation of edge computing, where intelligent machines see and act in the real world.

A new partnership between Patchwork Labs and Self Storage Manager embeds an AI agent deep into facility software, automating everything from calls to vendors.

NKGen Biotech signals a strategic pivot to Asia, leveraging its novel NK cell therapy, troculeucel, to tap into China's new, accelerated biotech pathways.

New guidelines for ankle arthritis, a condition hitting younger workers hard, expose major gaps in medical research and a market ripe for innovation.

YD Bio is expanding its U.S. lab network, but the real story is its strategy: turning diagnostic tests into a vast data engine to power the future of cancer research.

Revolution Medicines' zoldonrasib delivers high response rates in trials for RAS G12D pancreatic cancer, offering a beacon of hope against a lethal disease.

The new 312-unit Allegra at Cocoa development isn't just new housing; it's a barometer for the economic boom and growing pains of Florida's Space Coast.

A secretive $36M sole-source contract for Kratos reveals more than just a new missile system; it points to a strategic overhaul of the U.S. defense base.